Product Information
PAXLOVID 300-100 MG DOSE PACK is a brand product labeled by Pfizer Inc., priced at $49.2398 per EA under NDC 00069532130. Its NADAC has been published 123 times since Jan 17, 2024.
Manufacturer
Pfizer Inc.NDC
00069532130
Classification
Brand
Dosage Form
KIT
Last Updated
5/20/2026
Approval Type
New Drug (NDA)
FDA Application
NDA217188On Market Since
10/18/2023
Price Statistics
The NADAC for PAXLOVID 300-100 MG DOSE PACK has been published 123 times since Jan 17, 2024, and over the history we have for it it has risen 10.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $49.2398 per EA |
|---|---|
| All-time high | $49.2992 (May 13, 2026) |
| All-time low | $44.5332 (Apr 17, 2024) |
| 52-week high | $49.2992 |
| 52-week low | $47.8381 |
| Median price | $47.8414 |
| Average price | $47.1909 |
| Largest weekly change | +4.5% (Jul 3, 2024) |
| Weeks tracked | 123 |
| Tracking since | Jan 17, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PAXLOVID 300-100 MG DOSE PACK?
The current National Average Drug Acquisition Cost (NADAC) for PAXLOVID 300-100 MG DOSE PACK, manufactured by Pfizer Inc., is $49.2398 per EA (NDC 00069532130), effective May 20, 2026.
How has the price of PAXLOVID 300-100 MG DOSE PACK changed over time?
Over the history we have for it, the NADAC for PAXLOVID 300-100 MG DOSE PACK has risen 10.2%. It has been tracked across 123 weekly CMS publications since Jan 17, 2024.
What are the highest and lowest recorded NADAC prices for PAXLOVID 300-100 MG DOSE PACK?
Since Jan 17, 2024, the NADAC for PAXLOVID 300-100 MG DOSE PACK has ranged from a low of $44.5332 (Apr 17, 2024) to a high of $49.2992 (May 13, 2026), with a median of $47.8414 per EA.
Are there cheaper alternatives to PAXLOVID 300-100 MG DOSE PACK?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, PAXLOVID 300-100 MG DOSE PACK, is $49.2332 per EA — about 0% below PAXLOVID 300-100 MG DOSE PACK.
Who manufactures PAXLOVID 300-100 MG DOSE PACK?
PAXLOVID 300-100 MG DOSE PACK (NDC 00069532130) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification